Risk Factors for Treatment Failure with Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

Anti-osteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience multiple fractures while on treatment. Therefore, criteria for treatment failure have recently been defined. Using data from the Global Longitudinal study of Osteoporosis in Women (GLOW), we analyzed r...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Bone Miner Res
Prif Awduron: Díez-Pérez, Adolfo, Adachi, Jonathan D, Adami, Silvano, Anderson, Frederick A, Boonen, Steven, Chapurlat, Roland, Compston, Juliet E, Cooper, Cyrus, Gehlbach, Stephen H, Greenspan, Susan L, Hooven, Frederick H, LaCroix, Andrea Z, Nieves, Jeri W, Netelenbos, J Coen, Pfeilschifter, Johannes, Rossini, Maurizio, Roux, Christian, Saag, Kenneth G, Silverman, Stuart, Siris, Ethel S, Wyman, Allison, Rushton-Smith, Sophie K, Watts, Nelson B
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878143/
https://ncbi.nlm.nih.gov/pubmed/23794198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2023
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg